Skip to main content

Pharmaceutical Aseptic Transfer Market Expected to Witness Significant Growth till 2031

 According to BIS Research, pharmaceutical aseptic transfer refers to the use of products that promote the aseptic transfer of both solid and liquid pharmaceutical products at every stage of the lifecycle, from manufacturing to packaging and distribution.

According to this study, the global pharmaceutical aseptic transfer market was $855.2 million in 2021 and is projected to reach $2.55 billion by 2031.

Global Pharmaceutical Aseptic Transfer Market

The following factors are responsible for the increase in demand for pharmaceutical aseptic transfer:

  • Rapid expansion of the pharmaceutical industry
  • Significant rise in investment in the pharmaceutical industry
  • Implementation of stringent regulations for drug approval processes
  • Growing demand for automated products for aseptic transfer processes

The detailed study is a compilation of 27 market data tables and 226 figures spread through 270 pages. 

Check out the detailed table of content here →  https://bisresearch.com/requestsample?id=1344type=toc

Impact of COVID-19

The COVID-19 pandemic led to pharmaceutical companies investing heavily in RD and ramping up production of potentially life-saving drugs for COVID-19. The unprecedented demand for these drugs and the urgency to cater to the demand within a short span of time led to higher demand for the maintenance of an aseptic environment in order to ensure regulatory compliance and faster time-to-market. However, the trade and travel restrictions amidst the COVID-19 pandemic placed a higher burden on the supply chain, with the procurement of components and systems becoming more challenging.

Overall, while the supply side was negatively impacted, especially during the peak of the COVID-19 pandemic, the significantly high demand for aseptic solutions offset the negative impact and led to positive growth of the market in 2020 and 2021.

 

Global Pharmaceutical Aseptic Transfer Market Segmentation

 

Existing Competitive Landscape

The companies that are profiled have been selected based on primary research inputs gathered from network of industry experts and analyzing company coverage, product portfolio, and market penetration.

Some of the prominent established names in this market are:

•   ABC Transfer SAS
•   ATS Automation Tooling Systems, Inc.
•   Azbil Corporation
•   Castus GmbH Co. KG
•   ChargePoint Technology 
•   Dover Corporation
•   EnPro Industries, Inc.
•   Entegris Inc.
•   Ezi-Dock Systems Ltd.
•   Getinge AB
•   ILC Dover LP
•   JCE Biotechnology 
•   Rommelag
•   Sartorius AG
•   Single Use Support GmbH

 

Recent Developments in Global Pharmaceutical Aseptic Transfer Market

•    In June 2022, ChargePoint Technology acquired a single-use product and accessory manufacturer, Terracon.
•    In January 2022, ChargePoint Technology accelerated expansion to enhance services in the U.S. market.
•    In June 2022, Getinge AB launched its DPTE-EXO with sleeveless DPTE-BetaBag. This alpha port ensures automated aseptic transfer and assists in enhancing operational proficiency.
•    In November 2021, Getinge AB extended its presence in Vietnam by forming its legitimate unit, Getinge Vietnam.
•    In November 2021, Sartorius AG expanded its production capacities in France for storage and further innovation to meet the rising demands of the pharmaceutical industry.
•    In September 2021, Sartorius AG expanded its manufacturing facilities in China in biological drug discovery, process development, testing, and validation to meet growing local customer demand.
•    In March 2021, Arcline Investment Management acquired ChargePoint Technology to fuel an increased global presence.
•    In January 2021, Getinge AB expanded the production capacity of its DPTE BetaBags in the U.S. by establishing the manufacturing of these BetaBags at its site in Merrimack, New Hampshire.
•    In December 2020, Pall Corporation established a strategic partnership with Single Use Support GmbH to distribute the RoSS SHELL platform of the company globally.
•    In June 2020, ABS Transfer SAS raised $3.2 million (€3 million), in the series A funding round led by Go Capital, along with Bpifrance and the regional government of Centre-Val de Loire.

Demand – Drivers and Limitations

Following are the drivers for the global pharmaceutical aseptic transfer market:

•    Rapid Expansion of the Pharmaceutical Industry
•    Significant Rise of Investment in the Pharmaceutical Industry 
•    Implementation of Stringent Regulations for Drug Approval Processes
•    Growing Demand for Automated Products for Aseptic Transfer Processes

The market is expected to face some limitations too due to the following challenges:

•    Complex Development Cycle of Aseptic Transfer Systems and Requirement of Large Capital Investment for Installation
•    Lack of Skilled Personnel
•    Growing Preference for Refurbished Equipment

Why Should You Buy the Report?

This exclusive report on the global pharmaceutical aseptic transfer market will help in the following ways:

  •  Aid in the development of advanced pharmaceutical aseptic transfer products
  •  Aid in understanding the regulatory scenario of the market in different regions
  •  Aid in understanding the patent trend of the market
  •  Aid in targeting end users for increasing the adoption of pharmaceutical aseptic transfer products
  •  Support in analyzing the market opportunities
  •  Help to understand the competitive positioning of the key companies in the market

Request a FREE sample of this report here →  https://bisresearch.com/requestsample?id=1344type=download

Key Questions Answered in the Report:

  • What are the major market drivers, challenges, and opportunities in the global pharmaceutical aseptic transfer market?
  • What are the emerging trends within the global pharmaceutical aseptic transfer market?
  • What is the global pharmaceutical aseptic transfer market segmentation by system type, usability, transfer type, region, and end user?
  • How is each segment of the global pharmaceutical aseptic transfer market expected to grow during the forecast period, and what is the anticipated revenue generated by each of the segments by the end of 2031?
  • What are the significant developmental strategies implemented by the major players in order to sustain in the competitive market, and what are the key regulatory bodies controlling the entry of aseptic transfer products to the market?
  • Who are the leading players with significant offerings to the global pharmaceutical aseptic transfer market, and what is the current market dominance for each of these leading players?
  • What is the expected compound annual growth rate (CAGR) expected to be witnessed by the leading players in the market during the forecast period 2022-2031, and which system type is anticipated to have the most promising growth?
  • Who are the key manufacturers in the global pharmaceutical aseptic transfer market, and what are their contributions?
  • What is the growth potential of the global pharmaceutical aseptic transfer market in North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa?
  • What is the patent filing trend in the global pharmaceutical aseptic transfer market?

BIS Research Related Market Studies:

Aseptic Pharma Processing Market

Aseptic Pharma Processing Equipment Market

Comments

Popular posts from this blog

PP Compound Market for Automotive Industry Open Up New Revenue Opportunities

  The global PP compound market for automotive industry is expected to reach $17,324.8 million by 2031, with a CAGR of 5.6% during the forecast period 2021-2031. The growth in the market is expected to be driven mainly by the need to reduce the weight of vehicles and demand for cheaper products that can be used in automotive parts. Impact of COVID-19 on the Global Polypropylene (PP) Compound Market for Automotive Industry Due to the COVID–19 pandemic, the PP compound market was severely impacted like many other industries. Automotive production in 2020 saw a decline of almost 16% due to the impact of COVID-19. In order to control the spread of the virus, the majority of the countries around the globe imposed stay-at-home orders, which led to the shutting of many manufacturing plants. As the production of vehicles declined, the demand for PP compounds suffered negatively in the year 2020. Market Segmentation Global Polypropylene (PP) Compound Market for Automotive Industry by Applicatio

Growing Focus on Patient-Centered Healthcare led to Rise in Urgent Care Apps Market

Urgent care apps are intended to serve patients seeking urgent care by connecting them to a relevant specialist and facilitating further courses of action such as diagnosis, treatment, and monitoring.   Treatment can be offered remotely via text/audio/video calls, or help can be arranged to usher the patient to the nearest hospital. The widespread adoption of smartphones and increased demand for urgent and convenient access to care will be crucial to the market’s growth.  The global urgent care apps market was valued at $973.6 million in 2020 and is anticipated to grow to $10,150.5 million by the end of 2030 at a projected CAGR of 26.32% during the forecast period 2021-2030.   The aforementioned growth is based on the realistic forecast, which is the most likely growth scenario based on current market conditions. This scenario assumes that there will be no visible impact of COVID-19 beyond 2030. The changes in the market during that timeline can build upon the developments of

Neoantigen Cancer Vaccine Market Technology Developments and Future Growth

  Looking at the recent oncology care trends, the World Heart Foundation estimates the global cancer treatment expenditure to reach $XX billion in the year 2031.   The increase in overall burden provides an opportunity for several companies to step in and introduce their innovative products in the market. The emergence of the neoantigen cancer vaccine can be considered as an evident example of emerging oncology care that can possibly prevail over the existing hurdles of treatment un-specificity and safety benchmarks. The global neoantigen cancer vaccine industry analysis by BIS Research projects the market to grow at a significant CAGR of 77.73% during the forecast period 2024-2031. The  neoantigen cancer vaccine market  is expected to generate $35.5 million in revenue in 2024, owing to the expected launch of the first neoantigen vaccine, DC vaccine in the market. The neoantigen cancer vaccine market growth has been primarily attributed to major drivers in this market, such as rising p